<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To examine the relationship between the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E (APOE) epsilon4 genotype, medial temporal lobe <z:mpath ids='MPATH_127'>atrophy</z:mpath>, and white matter hyperintensities on magnetic resonance imaging in late-life <z:hpo ids='HP_0000726'>dementias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>DESIGN: Structural magnetic resonance imaging study using T2-weighted and proton density-weighted axial scans and T1-weighted coronal scans </plain></SENT>
<SENT sid="2" pm="."><plain>SETTING: Community-dwelling population of elderly patients prospectively chosen from a clinical case register of consecutive referrals to old age psychiatry services </plain></SENT>
<SENT sid="3" pm="."><plain>SUBJECTS: Twenty-five subjects with <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo> (by criteria of the National Institute of Neurological and <z:e sem="disease" ids="C0009460" disease_type="Mental or Behavioral Dysfunction" abbrv="">Communication Disorders</z:e> and <z:hpo ids='HP_0001297'>Stroke</z:hpo> and the <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's Disease</z:e> and Related Disorders Association; mean age, 77.8 years), 22 subjects with <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> (consensus criteria; mean age, 77.2 years), and 24 subjects with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (by criteria of the National Institute of <z:e sem="disease" ids="C1112108" disease_type="Disease or Syndrome" abbrv="">Neurological Disorders</z:e> and <z:hpo ids='HP_0001297'>Stroke</z:hpo> and the Association International pour la Recherche et l'Enseignement en Neurosciences; mean age, 76.9 years) were selected </plain></SENT>
<SENT sid="4" pm="."><plain>Subjects were well matched for age, sex, duration of illness, and cognitive function </plain></SENT>
<SENT sid="5" pm="."><plain>MAIN OUTCOME MEASURES: The APOE genotype was determined using the polymerase chain reaction method, and medial temporal lobe <z:mpath ids='MPATH_127'>atrophy</z:mpath> and white matter hyperintensities (periventricular and deep white matter) were visually rated using standardized scales </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: In <z:hpo ids='HP_0000001'>all</z:hpo> subjects with <z:hpo ids='HP_0000726'>dementia</z:hpo>, no significant associations were noted between APOE epsilon4 status and medial temporal lobe <z:mpath ids='MPATH_127'>atrophy</z:mpath> (mean score: 0 epsilon4 = 4.5, 1 epsilon4 = 4.5, and 2 epsilon4 = 4.3; P = .90), periventricular hyperintensities (0 epsilon4 = 3.3, 1 epsilon4 = 3.1, and 2 epsilon4 = 2.9; P = .83), and white matter hyperintensities (0 epsilon4 = 5.3, 1 epsilon4 = 4.9, and 2 epsilon4 = 4.9; P = .79) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The APOE epsilon4 allele does not determine medial temporal lobe <z:mpath ids='MPATH_127'>atrophy</z:mpath> or white matter lesions, as measured by magnetic resonance imaging in patients with <z:hpo ids='HP_0002511'>Alzheimer disease</z:hpo>, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, or <z:hpo ids='HP_0000726'>dementia</z:hpo> with <z:hpo ids='HP_0100315'>Lewy bodies</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Although APOE epsilon4 may modify the risk for acquiring <z:hpo ids='HP_0000726'>dementia</z:hpo>, this finding provides further evidence that APOE epsilon4 does not influence pathological processes thereafter </plain></SENT>
</text></document>